Start a new topic and get direct answers from the Expert Advice Community.
CREATE NEW TOPIC +Guest
You as distributor need to be in a complaint with MDR in the domain of how long will you keep the documents from the medical devices (10 years for all devices, and 15 years for class IIb implantable and class III). In the Medical device file, you need to have an EC certificate, Declaration of conformity, Label, and instruction of use, and in case of devices that need installation and service, some installation and service manual.
First is important to note that the main clauses of ISO 27001:2013 (i.e., clauses 4 to 10) are still valid. The 2013 version of the standard was confirmed in 2019, and the new version of the standard, expected to be published still in this year, will have modifications only related to Annex A.
Although the total number of controls had been reduced from 114 to 93, none of the old controls have been excluded (most of them have been merged), and you only have 11 new controls.
Considering that, in case you are currently compliant with ISO 27001:2013, your main effort will be on reviewing risks and legal requirements to check if these new controls need to be considered in your implementation.
The effort to transition to the 2022 revision is probably 10 to 20% of the time you needed to initially implement ISO 27001; alternatively, this effort can be cca 5% if you are using a tool like Conformio. Click here for more information: https://advisera.com/27001academy/iso-27001-transition-package/
For further information, see:
You asked "How do i put in place clauses 4.1.5 and 5.4 in the laboratory?"
To meet clause 4.1.5 requirements, a laboratory must use various operational activities such as audits, feedback from clients, evaluation of contracts and providers of services and products to identify risks to impartiality. Action must be taken to minimise or eliminate the identified risk, typically through a change in the process. For more information, see my response to a question Preparing risk analysis with regard to impartiality and confidentiality, at https://community.advisera.com/topic/preparing-risk-analysis-with-regard-to-impartiality-and-confidentiality
Clause 5.4 has to parts to the requirement. Firstly a laboratory must implement a system that ensures all client contractual obligations, legal obligations (e.g labour laws and occupational safety, health and environment laws) are met. Then depending on the sector, the requirements of the IS7025 accreditation body, any certification body, and any other association, for example a professional body must also be met and maintained.
The second part of the clause states that if a laboratory performs activities away from the main registered location, e.g in the filed or at a clients premises, it is the laboratory’s responsibility to make sure these requirements are still met.
No, we do not have a Change control procedure per se. Change control is both covered in the Document management procedure and in the Management review. There is no strict requirement for the documented procedure in requirement 4.1.4 in the ISO 13485:2016.
Clinical trials are not covered with this toolkit because there is no requirement in the MDR to be a part of the Quality management system (Article 10 Obligations of manufacturers, Point 9). We have in our toolkit the necessary documentation for clinical evaluation.
In the Documentation toolkit, there is a record Appendix 2 Training record where performance monitoring is defined within 3, 6, and 12 months.
Thanks for the reply. Exactly, we are doing the same thing as what you mentioned. We buy final product and release on the market.
Thank you again for your time and effort kristina.
No matter that you for now do not have classic sales, giving the license to another company and having some communication with them is part of the sales process. The sales process is not just sales of the final product to the final users, but rather all communication that you have with the companies that use your service.
Therefore, you need the sales procedure, but it will be specific for you for the communication with the licensed company.
Yes, a new design file needs to be created for each version of the facility.
The treatment of the listed risks needs to be defined manually by the user when filling in the wizard. The wizard will only point out where in the document the customization needs to be done.
In this case, the customization needs to be done in section 3.4.
It needs to be performed manually because each organization may have its own way to treat the same list of risks.
1. Should I write the exact listing of all the information assets covered?
2. Should I write the exact list of the information provided?
3. Should I write the exact list of applications / software covered?
4. Should I write the exact list of the physical offices covered?
5. Should I write the exact listing of the databases covered?
6. Should I write the exact list of websites / mobile applications covered?
7. If I want to include all the information assets of my organization is it sufficient to write: "The scope of the SGSI covers all the information assets of the Organization" or do I have to be explicit by detailing all the information assets?
This answer applies to questions 1 to 7.
The ISMS scope is normally defined in terms of general information (e.g., business information, customer information, R&D information, etc.), processes (SW development process, customer support process, sales process, etc.) or location (e.g., headquarters, an office, a building, etc.) to be protected, so you do not need to include assets in the definition of the ISMS scope.
For further information, see:
8. Do I have virtual machines on Microsoft Azure that run critical applications, should I specify that the scope only covers the applications installed on these virtual machines that are on Microsoft Azure? or should I also include the virtual machines and their contents?
When dealing with cloud services, you need to include in the ISMS only the elements you are responsible for. The other elements can be left out of the scope.
In this case, if you control the virtual machines (i.e., their maintenance and operation), then you need to include them in the ISMS. In case not, you only need to include the applications in the ISMS scope.
For further information, see:
9. We currently have corporate mail with GOOGLE, is mail a critical asset in our organization, should I also include it in its scope if a service provided by a third party? What considerations do you have in the writing in the link at the level of this service?
In this case, since GOOGLE provides email as a service, you need to include in the ISMS scope only the email data.
10. Currently we send our customers emails and massive newsletters that contain important business information, are these emails and newsletters sent through a provider's software, should I also include it in the scope of a service provided by a third party? What considerations do you have in the writing in the link at the level of this service?
In the ISMS scope, you need to include the reference to the data, and mention that related services are provided by third parties.
No, it means that you can sell all products. Class I must be in compliance with the MDR from May 2021. So, you have a very good client that follows everything necessary.